Takeda Pharmaceutical (TKPHF) Operating Income (2017 - 2025)
Historic Operating Income for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $1.1 billion.
- Takeda Pharmaceutical's Operating Income fell 1191.58% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $12.8 billion, marking a year-over-year increase of 4197.23%. This contributed to the annual value of $2.2 billion for FY2025, which is 5150.85% up from last year.
- Takeda Pharmaceutical's Operating Income amounted to $1.1 billion in Q4 2025, which was down 1191.58% from $6.8 billion recorded in Q3 2025.
- In the past 5 years, Takeda Pharmaceutical's Operating Income registered a high of $6.8 billion during Q3 2025, and its lowest value of -$67.9 million during Q1 2024.
- Its 5-year average for Operating Income is $1.9 billion, with a median of $1.3 billion in 2023.
- As far as peak fluctuations go, Takeda Pharmaceutical's Operating Income plummeted by 10533.05% in 2024, and later skyrocketed by 378809.27% in 2025.
- Takeda Pharmaceutical's Operating Income (Quarter) stood at $1.0 billion in 2021, then increased by 1.53% to $1.0 billion in 2022, then surged by 51.96% to $1.6 billion in 2023, then decreased by 21.24% to $1.2 billion in 2024, then dropped by 11.92% to $1.1 billion in 2025.
- Its Operating Income was $1.1 billion in Q4 2025, compared to $6.8 billion in Q3 2025 and $2.3 billion in Q2 2025.